Dennis Polk Sold TD SYNNEX Stock After Record Fiscal 2025 Results

Dennis Polk sold roughly $3.0M of TD SYNNEX stock on January 12, 2026, only a few days after the company reported record fiscal 2025 results. That makes this less interesting as a raw sell headline and more interesting as a post-results timing event.

Transaction snapshot

Jan. 12, 2026 sales	20,000 shares sold for about $3.0M
Related option activity	multiple same-day exercises also appeared in the filing
Shares after latest Form 4	27,581 directly held shares

Why it matters

TD SYNNEX reported record fiscal Q4 and full-year fiscal 2025 results on January 8, 2026. That backdrop matters because the January 12 sale happened after a clearly positive operating update, not after a visible disappointment. In other words, the transaction landed in a strength narrative, not a weak one.

That usually pushes the analysis away from “management is bailing” and toward “management is monetizing into strength.” Those are not the same message. The nuance is exactly why readers should pair this with the Form 4 explainer instead of treating every post-earnings sale the same way.

What the filing says about ownership

The latest Form 4 still showed 27,581 directly held shares after the transaction. That is a much smaller residual stake than some founder-led situations, but it also means the precise takeaway is not “full exit.” The better read is that Polk used a strong operating window to lighten exposure while keeping some direct ownership in place.

This is also a useful case for comparing transaction structure. The same-day option exercises matter. A sale bundled with exercise mechanics is a different signal from a plain discretionary open-market sale with no related option activity.

What to watch next

• Whether later Form 4s extend the same post-results pattern.
• Whether TD SYNNEX maintains the operating momentum that made January 2026 a favorable sale window.
• Whether the residual directly held stake keeps shrinking or stabilizes.
• Whether institutional holders interpret the company as a steady compounder or a post-peak beneficiary.